Trijardy Xr Tablet, Extended Release
Pricing Report NDC 0597-0385-77

Current NADAC: $5.62548 per EA · Effective Aug 19, 2026 · Est. package price $337.53 (60 EA)

Current Package Pricing Information

The current wholesale acquisition cost for Trijardy Xr (NDC 0597-0385-77) is $5.62548 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Aug 19, 2026.

As a a human prescription drug provided by Boehringer Ingelheim Pharmaceuticals, Inc., this medication is distributed in a 60 TABLET, EXTENDED RELEASE in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$5.62548
Per EA

Effective Date
Aug 19, 2026
Billable Units
60 EA
Estimated Package Price
$337.53
Data Status
As of Sep 09, 2026
C/I - Chain or Independent Pharmacy
Package NDC
Description
60 TABLET, EXTENDED RELEASE in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Jan 2021, the NADAC wholesale price for (NDC ) has moved within a range of $5.61890 to $10.10531 per EA. Over this 5 years and 6 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$5.6189 - $10.1053
Market Volatility
79.84% Variance
Latest Trend
0.03%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Aug 19, 2026 $5.62548 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Aug 19, 2026 $5.62548 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jul 22, 2026 $5.62701 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jul 22, 2026 $5.62701 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jun 17, 2026 $5.62205 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jun 17, 2026 $5.62205 EAC/I - Chain or Independent PharmacyCode 1B - Brand
May 20, 2026 $5.61967 EAC/I - Chain or Independent PharmacyCode 1B - Brand
May 20, 2026 $5.61967 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jan 01, 2026 $5.61890 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Jan 01, 2026 $5.61890 EAC/I - Chain or Independent PharmacyCode 3B - Brand
Jan 01, 2026 $5.61890 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Jan 01, 2026 $5.61890 EAC/I - Chain or Independent PharmacyCode 2B - Brand

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: September 09, 2026